Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabidiol as potential anticancer drug
Paola Massi, Marta Solinas, Valentina Cinquina, et al.
British Journal of Clinical Pharmacology (2012) Vol. 75, Iss. 2, pp. 303-312
Open Access | Times Cited: 207

Showing 1-25 of 207 citing articles:

From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo
Physiological Reviews (2016) Vol. 96, Iss. 4, pp. 1593-1659
Open Access | Times Cited: 414
Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?
Natalia Prevarskaya, Roman Skryma, Yaroslav Shuba
Physiological Reviews (2018) Vol. 98, Iss. 2, pp. 559-621
Open Access | Times Cited: 364
Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy
István Ujváry, L Hanŭs
Cannabis and Cannabinoid Research (2016) Vol. 1, Iss. 1, pp. 90-101
Open Access | Times Cited: 253
Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐HT1A receptors without diminishing nervous system function or chemotherapy efficacy
Sara Jane Ward, Sean D. McAllister, Rumi Kawamura, et al.
British Journal of Pharmacology (2013) Vol. 171, Iss. 3, pp. 636-645
Open Access | Times Cited: 250
Reactive oxygen species-mediated therapeutic response and resistance in glioblastoma
Eric A. Singer, Jonathon Judkins, Nathan Salomonis, et al.
Cell Death and Disease (2015) Vol. 6, Iss. 1, pp. e1601-e1601
Open Access | Times Cited: 223
Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
Serena Silvestro, Santa Mammana, Eugenio Cavalli, et al.
Molecules (2019) Vol. 24, Iss. 8, pp. 1459-1459
Open Access | Times Cited: 218
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
Headache The Journal of Head and Face Pain (2018) Vol. 58, Iss. 7, pp. 1139-1186
Closed Access | Times Cited: 211
Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: Novel anti‐tumor mechanisms of Cannabidiol in breast cancer
Mohamad Elbaz, Mohd W. Nasser, Janani Ravi, et al.
Molecular Oncology (2015) Vol. 9, Iss. 4, pp. 906-919
Open Access | Times Cited: 198
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Henry Lowe, Ngeh J. Toyang, Blair Steele, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 17, pp. 9472-9472
Open Access | Times Cited: 198
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid
Francesca Borrelli, Ester Pagano, Barbara Romano, et al.
Carcinogenesis (2014) Vol. 35, Iss. 12, pp. 2787-2797
Open Access | Times Cited: 197
A narrative review of molecular mechanism and therapeutic effect of cannabidiol (CBD)
Jiangling Peng, Mingjie Fan, Chelsea An, et al.
Basic & Clinical Pharmacology & Toxicology (2022) Vol. 130, Iss. 4, pp. 439-456
Open Access | Times Cited: 177
Molecular and Cellular Mechanisms of Action of Cannabidiol
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2023) Vol. 28, Iss. 16, pp. 5980-5980
Open Access | Times Cited: 55
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti, Janani Ravi, Ramesh K. Ganju
Oncotarget (2014) Vol. 5, Iss. 15, pp. 5852-5872
Open Access | Times Cited: 183
Cannabidiol Protects against Doxorubicin-Induced Cardiomyopathy by Modulating Mitochondrial Function and Biogenesis
Enkui Hao, Partha Mukhopadhyay, Zongxian Cao, et al.
Molecular Medicine (2015) Vol. 21, Iss. 1, pp. 38-45
Open Access | Times Cited: 154
An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
Paula Morales, Patricia H. Reggio, Nadine Jagerovic
Frontiers in Pharmacology (2017) Vol. 8
Open Access | Times Cited: 153
VDAC1 as Pharmacological Target in Cancer and Neurodegeneration: Focus on Its Role in Apoptosis
Andrea Magrì, Simona Reina, Vito De Pinto
Frontiers in Chemistry (2018) Vol. 6
Open Access | Times Cited: 145
Therapeutic potential of cannabis-related drugs
S P H Alexander
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2015) Vol. 64, pp. 157-166
Closed Access | Times Cited: 139
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect
Marta Solinas, Paola Massi, Valentina Cinquina, et al.
PLoS ONE (2013) Vol. 8, Iss. 10, pp. e76918-e76918
Open Access | Times Cited: 139
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
Uchini S. Kosgodage, Rhys R. Mould, Aine Brigette Henley, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 127
Safety and Pharmacokinetics of Oral Cannabidiol When Administered Concomitantly With Intravenous Fentanyl in Humans
Alex F. Manini, Georgia Yiannoulos, Mateus M. Bergamaschi, et al.
Journal of Addiction Medicine (2015) Vol. 9, Iss. 3, pp. 204-210
Open Access | Times Cited: 116
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids
Sean D. McAllister, Liliana Soroceanu, Pierre‐Yves Desprez
Journal of Neuroimmune Pharmacology (2015) Vol. 10, Iss. 2, pp. 255-267
Open Access | Times Cited: 114
Cannabidiol directly targets mitochondria and disturbs calcium homeostasis in acute lymphoblastic leukemia
Miguel Olivas-Aguirre, Liliana Torres-López, Salvador Valle‐Reyes, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 10
Open Access | Times Cited: 113
Integrating Cannabis into Clinical Cancer Care
Donald I. Abrams
Current Oncology (2016) Vol. 23, Iss. 11, pp. 8-14
Open Access | Times Cited: 112
Cannabidiol differentially regulates basal and LPS-induced inflammatory responses in macrophages, lung epithelial cells, and fibroblasts
Thivanka Muthumalage, Irfan Rahman
Toxicology and Applied Pharmacology (2019) Vol. 382, pp. 114713-114713
Open Access | Times Cited: 107
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol
Barbara Romano, Francesca Borrelli, Ester Pagano, et al.
Phytomedicine (2013) Vol. 21, Iss. 5, pp. 631-639
Closed Access | Times Cited: 106
Page 1 - Next Page

Scroll to top